Efficacy and tolerability after 24 weeks of treatment with telaprevir, pegylated interferon and ribavirin in cirrhotic HIV-HCV coinfected subjects

dc.contributor.author	Álvarez Díaz, Hortensia
dc.contributor.author	Mariño Callejo, Ana Isabel
dc.date.accessioned	2017-06-07T07:14:56Z
dc.date.available	2017-06-07T07:14:56Z
dc.date.issued	2014
dc.identifier.issn	0166-3542
dc.identifier.uri	http://hdl.handle.net/20.500.11940/4321
dc.language.iso	eng
dc.title	Efficacy and tolerability after 24 weeks of treatment with telaprevir, pegylated interferon and ribavirin in cirrhotic HIV-HCV coinfected subjects
dc.type	Artigo	es
dc.authorsophos	Genebat M
dc.authorsophos	Vera F
dc.authorsophos	Hernández-Quero J
dc.authorsophos	Domingo P
dc.authorsophos	Guardiola JM
dc.authorsophos	Martínez-Madrid O
dc.authorsophos	Martínez L
dc.authorsophos	de la Llana FG
dc.authorsophos	Sánchez-Villegas J
dc.authorsophos	Alvarez H
dc.authorsophos	Mariño A
dc.authorsophos	Lluch JF
dc.authorsophos	Martínez-Pérez MA
dc.authorsophos	Marín J
dc.authorsophos	Ruiz-Mateos E
dc.authorsophos	M, Leal
dc.identifier.doi	10.1016/j.antiviral.2014.01.019
dc.identifier.pmid	24491797
dc.identifier.sophos	14773
dc.journal.title	ANTIVIRAL RESEARCH
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Ferrol::Xerencia da Área de Ferrol::Medicina Interna
dc.page.initial	59
dc.page.final	61
dc.rights.accessRights	openAccess
dc.typesophos	Artículo Original
dc.volume.number	104

Files in this item

Files	Size	Format	View
There are no files associated with this item.